Envestnet Asset Management Inc Windtree Therapeutics Inc Transaction History

Envestnet Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$0.16 - $281.7 $16,789 - $29.6 Million	104,934 Added 97.79%	212,236 $36,000
Q3 2022 Nov 10, 2022	BUY	$0.3 - $306.0 $28,954 - $29.5 Million	96,515 Added 894.73%	107,302 $32,000
Q2 2022 Aug 03, 2022	BUY	$0.38 - $1.14 $281 - $845	742 Added 7.39%	10,787 $4,000
Q1 2022 May 04, 2022	BUY	$0.94 - $1.6 $9,442 - $16,072	10,045 New	10,045 $11,000
Q3 2021 Oct 07, 2021	SELL	$1.66 - $2.27 $63,488 - $86,818	-38,246 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$1.68 - $2.79 $3,212 - $5,334	1,912 Added 5.26%	38,246 $88,000
Q1 2021 May 04, 2021	BUY	$2.14 - $6.18 $77,754 - $224,544	36,334 New	36,334 $89,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $9.8M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.